Back to 
TUDOR INVESTMENT CORP ET AL
TUDOR INVESTMENT CORP ET AL
INO
Showing 0 of 2 quarters
Position history for TUDOR INVESTMENT CORP ET AL's holdings in INOVIO PHARMACEUTICALS INC
No. Tudor Investment exited its INO (Inovio Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 134,820 shares worth $68,758. Tudor Investment first reported INO in Q4 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.